approval

JB Chemicals & Pharma has USFDA approval for venlafaxine hydrochloride extended release tablets. | Tech Reddy

by
JB Chemicals & Pharma has USFDA approval for venlafaxine hydrochloride extended release tablets. | Tech Reddy

[ad_1] JB Chemicals & Pharmaceuticals Ltd has received ANDA approval from USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. By design, this product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precisely controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to Osmotica … Read more

JB Chemical has received USFDA approval for Venlafaxine Extended Release tablets | Tech Reddy

by
JB Chemical has received USFDA approval for Venlafaxine Extended Release tablets | Tech Reddy

[ad_1] JB Chemicals & Pharmaceuticals has received ANDA approval from USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precisely controlled release mechanism. The product generic approval is bioequivalent and therapeutically equivalent to Osmotica Pharmaceutical US LLC’s … Read more

Shionogi’s anti-COVID-19 tablet has received approval for emergency use | Tech Reddy

by
Shionogi’s anti-COVID-19 tablet has received approval for emergency use | Tech Reddy

[ad_1] The Ministry of Health on November 22 approved the use of an anti-COVID-19 drug produced by a domestic manufacturer for the first time, and shipments are expected to begin early next month. Xocova Oral Drug Shionogi & Co. developed by marks the first home-grown drug that can be prescribed for patients with mild symptoms, … Read more

Alembic Pharmaceuticals receives USFDA approval for Nifedipine tablets | Tech Reddy

by
Alembic Pharmaceuticals receives USFDA approval for Nifedipine tablets | Tech Reddy

[ad_1] Alembic Pharmaceuticals Limited has announced that it has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg. USFDA approved ANDA therapeutically approved by Pfizer Inc. equivalent to the company’s Procardia XL Extended-Release tablets, 30 mg, 60 mg and 90 mg. … Read more

No approval of new stone crusher outside specified area: Govt Gurgaon news | Tech Reddy

by
No approval of new stone crusher outside specified area: Govt Gurgaon news | Tech Reddy

[ad_1] Gurugram: To prevent environmental degradation, Haryana has decided not to allow setting up of new stone-crushing units outside Gurugram, Faridabad and identified areas. Palwal A new draft notification by the Department of Environment and Climate Change states the new rules for setting up such units near forests, national highways, educational institutions, roads, water bodies … Read more

Ascletis’ monkeypox pill receives IND approval from FDA | Tech Reddy

by
Ascletis’ monkeypox pill receives IND approval from FDA | Tech Reddy

[ad_1] Ascletis Pharma’s monkeypox treatment has received approval from the US Food and Drug Administration (FDA) for a New Drug (IND) application. The FDA made its decision based on the available data, and Askletis can now proceed to a Phase 1b clinical trial to evaluate the safety, tolerability, efficacy and pharmacokinetics of the pill in … Read more

ANI Pharmaceuticals announces FDA approval and USP launch of trimethoprim tablets | Tech Reddy

by
ANI Pharmaceuticals announces FDA approval and USP launch of trimethoprim tablets | Tech Reddy

[ad_1] BAUDET, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or Company) (Nasdaq: ANIP) announced today that it has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for trimethoprim tablets USP, 100 mg. ANI’s Trimethoprim tablets are the generic version of the Reference List Drug (RLD) of the same brand name. … Read more